New form on the way for Schedules I & II drugs
DEA proposes a rule that would create a new format for ordering Schedule I and/or II controlled substances.
The end of carbon copies may well be nigh. DEA has proposed a rule that would eliminate the three-sheet carbon copy format for ordering Schedule I and Schedule II controlled substances. Instead, a new single-page form would be created that would include new security features. DEA will preprint the new form with an embedded watermark of the DEA emblem, making it more difficult to copy for counterfeit purposes. Users will have to make photocopies of the form for their records, which will then display "copy" on the form as another security feature. Under the rule, once the new single-sheet form is in use, the current three-part form will be phased out and will no longer be issued by DEA. The DEA will accept
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
